Aspen Pharmacare (APNHY)
OTHER OTC:APNHY
Holding APNHY?
Track your performance easily

Aspen Pharmacare (APNHY) Financial Statements

18 Followers

Aspen Pharmacare Financial Overview

Aspen Pharmacare's market cap is currently ―. The company's EPS TTM is $0.529; its P/E ratio is 18.62; and it has a dividend yield of 1.23%. Aspen Pharmacare is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Jun 22Dec 21Jun 21Dec 20
Income Statement-
Total RevenueRs 19.15BRs 19.23BRs 19.38BRs 37.77BRs 18.63B
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsRs 8.04BRs 6.18BRs 7.88BRs 8.55BRs 9.79B
Total AssetsRs 120.58BRs 111.38BRs 117.34BRs 109.68BRs 124.21B
Total DebtRs 26.80BRs 22.25BRs 27.19BRs 24.87BRs 37.48B
Net DebtRs 18.75BRs 16.06BRs 19.31BRs 16.33BRs 27.68B
Total Liabilities-----
Stockholders EquityRs 75.21BRs 70.94BRs 71.96BRs 65.63BRs 66.35B
Cash Flow-
Free Cash Flow-----
Operating Cash FlowRs 1.71BRs 5.37BRs 1.76BRs 6.83BRs 1.74B
Investing Cash Flow-----
Financing Cash Flow-----
Currency in ZAR

Aspen Pharmacare Earnings and Revenue History

Aspen Pharmacare Debt to Assets

Aspen Pharmacare Cash Flow

Aspen Pharmacare Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis